SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-004688
Filing Date
2022-02-11
Accepted
2022-02-11 08:01:17
Documents
61
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q ktra-10q_20211231.htm   iXBRL 10-Q 2820303
2 EX-31.1 ktra-ex311_7.htm EX-31.1 21567
3 EX-31.2 ktra-ex312_8.htm EX-31.2 21293
4 EX-32.1 ktra-ex321_6.htm EX-32.1 8850
5 EX-32.2 ktra-ex322_9.htm EX-32.2 8909
6 GRAPHIC gva2ahkifefb000001.jpg GRAPHIC 76288
7 GRAPHIC gva2ahkifefb000002.jpg GRAPHIC 40295
  Complete submission text file 0001564590-22-004688.txt   9431721

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ktra-20211231.xsd EX-101.SCH 69390
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ktra-20211231_cal.xml EX-101.CAL 28113
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ktra-20211231_def.xml EX-101.DEF 237711
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ktra-20211231_lab.xml EX-101.LAB 448361
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ktra-20211231_pre.xml EX-101.PRE 354018
55 EXTRACTED XBRL INSTANCE DOCUMENT ktra-10q_20211231_htm.xml XML 1719326
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 22616808
SIC: 2834 Pharmaceutical Preparations